DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20184784

Programmatic evaluation of mass drug administration for elimination of lymphatic filariasis and reasons for non-compliance in Gulbarga district, Karnataka in 2015

S. J. Naresh Kumar, B. N. Sunil

Abstract


Background: Mass drug administration (MDA) to eliminate lymphatic filariasis (LF) is conducted once annually in the identified endemic districts of the country. MDA implementation is assessed by appointed independent teams within 2-3 weeks of the activity to suggest mid-term corrections and strengthen the on-going programme. This study was undertaken to assess the process of MDA implementation, drug coverage and compliance and to identify the reasons for non-compliance.

Methods: A survey of four clusters comprising of three rural and one urban area was conducted in Gulbarga, during the third week following the MDA campaign in the district. Information pertaining to the MDA beneficiaries of the 124 evaluated households was collected over a period of three days using a structured proforma. The process of MDA implementation was evaluated at the district, taluk and primary health centre (PHC) levels.

Results: From the information collected on 673 inmates of the households surveyed, the coverage and compliance rates of 87.5 and 60.9% respectively was found for diethylcarbamazine citrate and albendazole distribution and consumption. The important reasons for non–compliance to swallow the drugs identified were the beneficiaries being out of station during the campaign, was not aware of it, the drug distributer did not visit the beneficiaries house and fear of side effects of the drugs.

Conclusions: Efforts to improve the compliance to consumption of the anti-filarial drugs at Gulbarga district is required for elimination of LF. 


Keywords


Lymphatic filariasis, Coverage, Compliance, Mass drug administration

Full Text:

PDF

References


Managing morbidity and preventing disability in the Global programme to eliminate lymphatic filariasis: WHO position statement. WHO Weekly Epidemiological Rec 2011;86:581. Available from: www.ncbi.nlm.nih.gov. Accessed on 03 Mar 2016.

Guidelines on filariasis control in India and its elimination. Delhi: Directorate of National Vector Borne Disease Control Programme 2009;7-40. Available at: www.scopemed.org. Accessed on 05 Mar 2016.

Annual report 2010-2011. Department of Health and Family Welfare, Ministry of Health and Family Welfare, Government of India. Available at: mohfw.nic.in. Accessed on 21 February 2016.

Pattanshetty S, Kumar A, Kumar R, Rao CR, Badiger S, Rashmi R, et al. Mass drug administration to eliminate lymphatic filariasis in Southern India. AMJ. 2010;3(13):847-50.

Ravish KS, Ranganath TS, Riyaz Basha S. Coverage and compliance of mass drug administration for elimination of lymphatic filariasis in endemic areas of Bijapur district, Karnataka. Int J Basic Med Sci. 2011;2(2):86-9.

Patel PK. Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts. Indian J Community Med. 2012;37(2):101-6.

Kumar A, Kumar P, Nagaraj K, Nayak D, Lena A, Ashok K. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India. J Vector Borne Dis. 2009;46:237-40.

Ranganath BG. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India. J Vector Borne Dis. 2010;47:61-4.

Sanjay TV, Kishore SG, Gowda G, Ravi KK. An evaluation of Mass Drug Administration (MDA) for the elimination of lymphatic filariasis in Raichur District, Karnataka. Indian J Prev Soc Med. 2012;43(2):197-201.

Shetty A, Santhuram AN, Nareshkumar SJ. Assessing coverage and compliance of mass drug administration under elimination of Lymphatic Filariasis program in Yadgir district, Karnataka. Int J Med Sci Public Health. 2012;1:71-4.

Kulkarni P, Kumar R, Rajegowda RM, Channabasappa HG, Ashok NC. MDA Program against lymphatic filariasis: Are we on the path to success? Experience from Uttara Kannada District, Karnataka. Int J Med Public Health. 2014;4:243-6.

Mahalakshmy T, Kalaiselvan G, Parmar J, Dongre A. Coverage and compliance to diethylcarbamazine in relation to Filaria prevention assistants in rural Puducherry, India. J Vector Borne Dis. 2010;47:113-5.

Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Dis. 2008;45:313-20.

Agrawal VK, Sashindran VK. Lymphatic Filariasis in India: Problems, Challenges and New Initiatives. MJAFI. 2006;62:359-62.

Kumar, Sanjay. India's revised filaria control strategy. The Lancet 1996;347:187.

Government of India. Operational Guidelines on Elimination of Lymphatic Filariasis 2005. Available at: http://nvbdcp.gov.in/home.htm. Accessed on 21 February 2016.